Terms: = Gastric cancer AND FAT4, ENSG00000196159, 79633
22 results:
1. Multiregional Sequencing Analysis Reveals Extensive Genetic Heterogeneity in gastric Tumors from Latinos.
Toal TW; Estrada-Florez AP; Polanco-Echeverry GM; Sahasrabudhe RM; Lott PC; Suarez-Olaya JJ; Guevara-Tique AA; Rocha S; Morales-Arana A; Castro-Valencia F; Urayama S; Kirane A; Wei D; Rios-Sarabia N; Medrano R; Mantilla A; Echeverry de Polanco M; Torres J; Bohorquez-Lozano ME; Carvajal-Carmona LG
Cancer Res Commun; 2022 Nov; 2(11):1487-1496. PubMed ID: 36970058
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of the mutation patterns between tumor tissue and cell-free DNA in stage IV gastric cancer.
Kung CY; Fang WL; Hung YP; Huang KH; Chen MH; Chao Y; Lin SC; Li AF; Lo SS; Wu CW
Aging (Albany NY); 2023 Feb; 15(3):777-790. PubMed ID: 36779847
[TBL] [Abstract] [Full Text] [Related]
3. Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract.
Wu H; Yu Z; Liu Y; Guo L; Teng L; Guo L; Liang L; Wang J; Gao J; Li R; Yang L; Nie X; Su D; Liang Z
Cancer Commun (Lond); 2022 Dec; 42(12):1367-1386. PubMed ID: 36264285
[TBL] [Abstract] [Full Text] [Related]
4. SOCS3 gene silencing does not occur through methylation and mutations in gastric cancer.
Al Saqri A; Malgundkar SH; Al Kindi F; Gupta I; Al Moundhri M; Tamimi Y
Hum Cell; 2022 Jul; 35(4):1114-1125. PubMed ID: 35596898
[TBL] [Abstract] [Full Text] [Related]
5. Identification of New Genes Involved in Germline Predisposition to Early-Onset gastric cancer.
Herrera-Pariente C; Capó-García R; Díaz-Gay M; Carballal S; Muñoz J; Llach J; Sánchez A; Bonjoch L; Arnau-Collell C; Soares de Lima Y; Golubicki M; Jung G; Lozano JJ; Castells A; Balaguer F; Bujanda L; Castellví-Bel S; Moreira L
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525650
[TBL] [Abstract] [Full Text] [Related]
6. Deep Targeted Sequencing and Its Potential Implication for cancer Therapy in Chinese Patients with gastric Adenocarcinoma.
Yu P; Wang Y; Yu Y; Wang A; Huang L; Zhang Y; Liu W; Wu H; Yao M; Du YA; Cheng X
Oncologist; 2021 May; 26(5):e756-e768. PubMed ID: 33511732
[TBL] [Abstract] [Full Text] [Related]
7. Analysis of genomic pathogenesis according to the revised Bethesda guidelines and additional criteria.
Kim JC; Kim JH; Ha YJ; Kim CW; Tak KH; Yoon YS; Kwon YH; Roh SA; Cho DH; Kim SK; Kim SY; Kim YS
J Cancer Res Clin Oncol; 2021 Jan; 147(1):117-128. PubMed ID: 32960359
[TBL] [Abstract] [Full Text] [Related]
8. Integrated characterisation of cancer genes identifies key molecular biomarkers in stomach adenocarcinoma.
Wang H; Shen L; Li Y; Lv J
J Clin Pathol; 2020 Sep; 73(9):579-586. PubMed ID: 32034058
[TBL] [Abstract] [Full Text] [Related]
9. Essential Oil from
Zhang Y; Xin C; Qiu J; Wang Z
Molecules; 2019 Oct; 24(21):. PubMed ID: 31731517
[TBL] [Abstract] [Full Text] [Related]
10. Neoantigens Derived from Recurrently Mutated Genes as Potential Immunotherapy Targets for gastric cancer.
Zhou J; Zhao W; Wu J; Lu J; Ding Y; Wu S; Wang H; Ding D; Mo F; Zhou Z; Teng L; Chen S
Biomed Res Int; 2019; 2019():8103142. PubMed ID: 31312661
[TBL] [Abstract] [Full Text] [Related]
11. miR-107 regulates growth and metastasis of gastric cancer cells via activation of the PI3K-AKT signaling pathway by down-regulating fat4.
Wang L; Li K; Wang C; Shi X; Yang H
Cancer Med; 2019 Sep; 8(11):5264-5273. PubMed ID: 31297980
[TBL] [Abstract] [Full Text] [Related]
12. fat4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis.
Wei R; Xiao Y; Song Y; Yuan H; Luo J; Xu W
J Exp Clin Cancer Res; 2019 Mar; 38(1):112. PubMed ID: 30832706
[TBL] [Abstract] [Full Text] [Related]
13. MiR-93-5p promotes gastric cancer-cell progression via inactivation of the Hippo signaling pathway.
Li L; Zhao J; Huang S; Wang Y; Zhu L; Cao Y; Xiong J; Deng J
Gene; 2018 Jan; 641():240-247. PubMed ID: 29045821
[TBL] [Abstract] [Full Text] [Related]
14. Epigenetic inactivation of fat4 contributes to gastric field cancerization.
Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
[TBL] [Abstract] [Full Text] [Related]
15. fat4 functions as a tumour suppressor in gastric cancer by modulating Wnt/β-catenin signalling.
Cai J; Feng D; Hu L; Chen H; Yang G; Cai Q; Gao C; Wei D
Br J Cancer; 2015 Dec; 113(12):1720-9. PubMed ID: 26633557
[TBL] [Abstract] [Full Text] [Related]
16. fat4 suppression induces Yap translocation accounting for the promoted proliferation and migration of gastric cancer cells.
Ma L; Cui J; Xi H; Bian S; Wei B; Chen L
Cancer Biol Ther; 2016; 17(1):36-47. PubMed ID: 26575609
[TBL] [Abstract] [Full Text] [Related]
17. Gene mutations in gastric cancer: a review of recent next-generation sequencing studies.
Lin Y; Wu Z; Guo W; Li J
Tumour Biol; 2015 Sep; 36(10):7385-94. PubMed ID: 26364057
[TBL] [Abstract] [Full Text] [Related]
18. An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versa.
Yamamoto H; Watanabe Y; Maehata T; Morita R; Yoshida Y; Oikawa R; Ishigooka S; Ozawa S; Matsuo Y; Hosoya K; Yamashita M; Taniguchi H; Nosho K; Suzuki H; Yasuda H; Shinomura Y; Itoh F
World J Gastroenterol; 2014 Apr; 20(14):3927-37. PubMed ID: 24744582
[TBL] [Abstract] [Full Text] [Related]
19. gastric cancer-molecular and clinical dimensions.
Wadhwa R; Song S; Lee JS; Yao Y; Wei Q; Ajani JA
Nat Rev Clin Oncol; 2013 Nov; 10(11):643-55. PubMed ID: 24061039
[TBL] [Abstract] [Full Text] [Related]
20. Function and cancer genomics of FAT family genes (review).
Katoh M
Int J Oncol; 2012 Dec; 41(6):1913-8. PubMed ID: 23076869
[TBL] [Abstract] [Full Text] [Related]
[Next]
